This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ, bladder
CD2_INSITU_BLADDER
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
516945 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1172 |
4. Check minimum number of eventsNone |
1172 |
5. Include endpointsNone |
1172 |
6. Filter based on genotype QC (FinnGen only) |
1135 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D09
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, bladder
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1135 | 215 | 920 |
| Unadjusted period prevalence (%) | 0.36 | 0.08 | 0.42 |
| Median age at first event (years) | 71.88 | 68.75 | 72.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1172
- Matched controls
- 11720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ZX136
NOMESCO Finland
Intravesicalis
52.8
322.4
187
42
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
126.6
307.7
692
132
UKC02
NOMESCO Finland
Cystoscopy
115.0
307.7
1121
1880
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
148.8
307.7
761
144
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
75.2
307.7
477
106
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
79.3
307.7
367
67
R31
ICD-10 Finland
Unspecified haematuria
12.5
307.7
684
1179
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
188.2
307.7
591
63
KCD02
NOMESCO Finland
Transurethral resection of bladder
129.0
307.7
774
174
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
11176.8
307.7
828
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
87.6
307.7
347
56
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
38.2
301.3
190
59
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
31.6
246.2
164
60
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
+∞
161.3
151
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
61.0
152.1
85
15
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
62.1
145.4
81
14
KCW96
NOMESCO Finland
Other operations on bladder
38.4
143.5
89
25
WX320
NOMESCO Finland
Spinalanesthesy
4.3
132.0
573
2138
U06
ICPC
Haematuria
8.0
106.9
155
218
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
18.3
106.7
87
51
UKB02
NOMESCO Finland
Retrograde ureteroscopy
17.3
100.2
84
52
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
1043.2
99.6
96
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
40.6
95.1
58
15
KH1AD
NOMESCO Finland
CT of urinary organs
7.4
88.7
137
206
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
13.0
86.5
85
70
XKD00
NOMESCO Finland
Uroflowmetry
3.2
81.5
517
2310
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.6
81.3
222
565
TKC20
NOMESCO Finland
Catheterisation of bladder
4.3
79.3
239
656
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.2
75.0
443
1882
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.3
67.5
103
152
WX402
NOMESCO Finland
General anaesthesia
3.0
59.1
352
1473
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
58.2
459
2225
WX224
NOMESCO Finland
Blockade of obturius nerve
152.4
55.4
58
*
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
22.4
52.7
39
18
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
51.5
262
995
N30.0
ICD-10 Finland
Acute cystitis
3.3
48.7
220
777
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.1
47.6
65
84
J01MA02
ATC
ciprofloxacin; systemic
2.4
47.5
627
3779
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
233.8
44.2
45
*
ZXC20
NOMESCO Finland
Use of chemical agents
5.7
43.4
84
157
KCB00
NOMESCO Finland
Biopsy of bladder
16.9
42.8
36
22
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.8
41.9
59
79
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.7
40.5
66
104
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
14.8
40.1
36
25
KED22
NOMESCO Finland
Transurethral resection of prostate
2.9
36.9
199
770
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
36.7
35
*
4CX01, ,
NOMESCO Finland
190.8
36.0
37
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
10.3
34.6
39
39
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
32.8
277
1333
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
13.2
32.4
31
24
KH1DD
NOMESCO Finland
CT urography of urinary organs
37.6
31.7
40
11
G04BD12
ATC
mirabegron; oral
2.5
30.6
232
1060
ZXE00
NOMESCO Finland
One hour or less
2.0
29.5
515
3275
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
28.4
234
1107
C66
ICD-10 Finland
Malignant neoplasm of ureter
40.1
28.2
35
9
KCC10
NOMESCO Finland
Cystoprostatectomy
8.0
26.5
36
46
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
26.1
25
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
5.2
26.1
54
107
KDV10
NOMESCO Finland
Internal urethrotomy
5.0
25.7
56
116
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.6
25.0
61
139
R33
ICD-10 Finland
Retention of urine
2.4
25.0
207
977
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
32.8
24.7
32
10
G04CA02
ATC
tamsulosin; oral
1.9
24.6
567
3888
U76
ICPC
Malignant neoplasm of bladder
20.6
24.4
36
18
A98
ICPC
Health maint/preventive medicine
3.9
22.8
1121
9958
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
41.0
22.7
28
7
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
5.8
22.7
42
75
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.9
22.5
69
187
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
21.3
180
853
JN4AD
NOMESCO Finland
Body CT examination
2.3
21.2
191
931
U07
ICPC
Urine symptom/complaint other
2.7
21.2
125
502
N30.9
ICD-10 Finland
Cystitis, unspecified
3.1
21.0
89
298
KBV10
NOMESCO Finland
Removal of stent from ureter
6.9
20.0
31
46
J01EA01
ATC
trimethoprim; systemic
2.0
19.9
271
1542
N02BE01
ATC
paracetamol; systemic, rectal
2.4
19.2
1053
9200
KCD30
NOMESCO Finland
Destruction of tumour of bladder
35.0
18.9
24
7
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
7.2
18.3
27
38
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
67.7
17.8
20
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
16.1
458
3222
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.6
16.0
38
85
J01DB01
ATC
cefalexin; oral
1.9
15.8
938
8012
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
26.7
15.6
21
8
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
38.6
15.4
19
5
KC1GB
NOMESCO Finland
Cystography with X-ray
4.6
15.2
36
80
J01MA12
ATC
levofloxacin; systemic
1.8
14.7
281
1762
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
14.6
14
*
KBH20
NOMESCO Finland
Replantation of ureter
27.6
14.3
19
7
U29
ICPC
Urinary symptom/complaint other
3.2
14.0
57
186
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
13.6
412
2915
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
13.6
13
*
WZC30
NOMESCO Finland
Teaching
1.8
13.1
219
1315
B02AA02
ATC
tranexamic acid; systemic
2.2
13.1
115
551
N21.0
ICD-10 Finland
Calculus in bladder
4.2
13.0
34
82
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
11.7
12.8
23
20
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.3
12.7
48
150
G04CA01
ATC
alfuzosin; oral
1.7
12.5
280
1827
UKD02
NOMESCO Finland
Urethroscopy
6.3
12.5
21
34
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
24.6
12.5
17
7
SPAT1167
SPAT
Insertion of urinary catheter
2.6
12.3
71
281
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
12.0
744
6155
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
47.2
11.9
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.9
622
4953
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
11.9
206
1249
SPAT1263
SPAT
Sampling
1.6
11.7
479
3609
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
11.5
448
3333
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
11.5
11
*
SPAT1262
SPAT
Handing over of treatment supplies
1.7
10.9
257
1692
KBD00
NOMESCO Finland
Partial excision of ureter
43.7
10.9
13
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
7.8
10.4
23
30
KDE20
NOMESCO Finland
Removal of foreign body from urethra
4.2
10.4
27
65
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
3.3
10.3
39
122
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
19.0
10.3
15
8
U05
ICPC
Urination problems other
2.2
10.2
88
418
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
10.2
168
1001
WX702
NOMESCO Finland
Supraglottic ventilation device
2.4
10.0
70
305
TKC22
NOMESCO Finland
Catheterisation instruction
2.6
9.7
55
216
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
9.6
86
416
G04BD08
ATC
solifenacin; oral
2.0
9.5
99
506
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
100.8
9.4
10
*
U01
ICPC
Dysuria/painful urination
2.3
9.2
71
323
R39.1
ICD-10 Finland
Other difficulties with micturition
2.5
9.2
57
235
U13
ICPC
Bladder symptom/complaint other
2.8
9.1
44
159
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
9.1
57
236
KBB00
NOMESCO Finland
Biopsy of ureter
37.0
9.0
11
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
8.9
365
2713
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
8.9
480
3769
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.5
8.9
53
214
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.8
8.8
26
69
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
8.6
85
426
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.4
8.5
57
243
A02BC02
ATC
pantoprazole; systemic
1.5
8.5
769
6630
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
8.5
74
353
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.5
8.5
29
85
TKD00
NOMESCO Finland
Dilatation of urethra
4.3
8.4
21
49
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.3
8.4
31
96
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
8.3
532
4297
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.6
8.2
18
24
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.0
166
1053
J01CA08
ATC
pivmecillinam; oral
1.6
7.9
218
1484
Z3231
NOMESCO Finland
Registered nurse
1.5
7.8
317
2343
KA3EB
NOMESCO Finland
Antegrade pyelography
6.4
7.7
19
30
KGH10
NOMESCO Finland
Operation for phimosis
2.4
7.3
51
222
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
6.9
7.3
17
25
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.3
676
5776
P17
ICPC
Tobacco abuse
4.2
7.3
19
46
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
7.3
63
301
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.2
433
3432
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
7.2
273
1986
SPAT1312
SPAT
General health counselling
1.5
7.2
329
2483
B01AB10
ATC
tinzaparin; parenteral
1.7
7.1
120
718
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
8.0
7.1
15
19
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
4.2
7.0
18
43
G04CB01
ATC
finasteride; oral
1.5
7.0
243
1737
U02
ICPC
Urinary frequency/urgency
1.7
6.9
131
810
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.9
484
3934
OAB50, ,
SPAT
2.0
6.9
73
377
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.5
6.8
222
1564
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
6.6
141
899
T90
ICPC
Diabetes non-insulin dependent
1.4
6.6
323
2464
R30.0
ICD-10 Finland
Dysuria
2.4
6.6
45
195
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.5
6.5
207
1449
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
6.5
319
2435
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
3.4
6.4
22
65
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.3
534
4454
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
6.2
108
653
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.1
6.2
55
266
SPAT1260
SPAT
Consultation of another employee
1.5
6.1
199
1398
JN4BD
NOMESCO Finland
Extensive body CT
1.6
6.1
144
943
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
409
3286
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
938
4052
7.59
202.71
9.7
3.4
—
—
—
0
0
640
2384
4.71
152.41
6.4
2.7
3.50
3.51
e6/l
0.01
602
2157
765
3408
4.58
139.59
10.9
3.4
407.15
101.24
e6/l
1.44
681
2725
711
3086
4.32
132.39
10.2
3.4
0.19
0.51
e6/l
8.00
636
2427
1084
6581
9.62
127.90
14.0
4.5
28.24
1869.07
e6/l
1.18
25
120
785
3773
4.27
123.64
12.0
3.9
137.04
117.02
e6/l
0.20
706
2865
470
1942
3.37
85.30
9.6
2.9
0.93
0.99
e6/l
0.19
379
1180
818
4760
3.38
81.38
3.4
2.9
—
—
—
0
0
442
1840
3.25
78.01
10.5
3.1
1.07
1.16
e6/l
0.17
350
1085
772
4648
2.94
66.34
8.1
5.0
0.00
0.00
estimate
-0.00
204
914
775
4697
2.92
65.37
6.2
3.8
0.00
0.00
estimate
0.35
219
978
775
4729
2.89
63.93
6.3
3.8
0.00
0.00
estimate
-0.00
191
873
889
6302
2.70
46.80
5.6
5.3
6.87
6.93
mmol/l
0.37
861
5967
194
668
3.28
44.55
7.8
2.8
0.13
0.30
e6/l
2.79
194
659
1107
9330
4.36
34.06
22.6
18.2
30.36
28.74
mg/l
0.77
963
7655
778
5610
2.15
32.75
21.1
19.6
1.32
1.40
inr
1.31
258
1594
1137
9936
5.83
29.52
28.5
21.6
139.56
139.64
mmol/l
0.50
1121
9682
1137
9953
5.77
29.07
28.8
21.8
4.03
4.02
mmol/l
0.32
1120
9691
551
3621
1.98
28.45
6.9
4.1
—
—
—
0
0
1057
8872
2.95
28.41
24.7
17.1
71.76
73.98
ml/min/173m2
3.01
961
7411
1130
9922
4.88
27.07
29.9
21.6
92.21
88.23
umol/l
2.27
1130
9916
1142
10152
5.88
25.85
35.1
26.5
235.05
232.51
e9/l
0.72
1117
9850
1142
10152
5.88
25.85
35.2
26.7
39.90
39.97
%
0.14
1061
9338
1142
10154
5.87
25.80
35.2
26.5
4.43
4.45
e12/l
0.59
1115
9809
1142
10154
5.87
25.80
35.1
26.5
7.18
6.95
e9/l
2.75
1115
9810
1142
10156
5.86
25.75
35.4
26.7
133.29
135.23
g/l
3.61
1129
9964
830
6448
1.98
24.48
5.8
5.5
2.62
3.28
ug/l
1.42
746
5722
943
7709
2.14
23.57
8.9
8.2
78.57
80.62
u/l
0.77
895
7237
400
2569
1.85
20.39
3.1
2.7
—
—
—
0
0
1110
9902
3.29
20.31
12.7
11.7
25.73
26.39
u/l
0.68
1067
9484
410
2663
1.83
20.09
7.0
4.1
0.00
0.00
estimate
0.50
184
843
704
5428
1.74
18.49
7.1
6.8
11.03
12.79
umol/l
4.92
676
5173
860
7076
1.81
17.46
4.3
4.2
15.59
13.91
mm/h
1.79
767
6454
393
2642
1.73
16.42
4.8
4.2
84.34
82.08
%
0.95
388
2584
709
5580
1.68
16.29
9.3
9.3
4.54
4.40
e9/l
0.85
608
4866
687
5363
1.68
16.27
7.7
7.6
1.21
1.20
mmol/l
0.46
579
4528
615
4674
1.66
16.08
6.0
5.3
34.37
34.55
g/l
0.35
574
4345
578
4387
1.63
14.70
2.5
2.2
—
—
—
0
0
212
1234
1.88
14.11
4.8
3.8
—
—
—
0
0
593
4571
1.60
13.84
5.6
6.0
59.58
58.65
%
1.06
558
4278
601
4648
1.60
13.83
5.8
6.2
24.64
25.68
%
1.35
564
4350
627
4911
1.60
13.58
6.9
6.6
1.21
1.20
mmol/l
0.65
565
4457
1034
9247
2.00
13.32
5.7
5.2
6.25
6.16
mmol/l
1.42
900
8258
909
7830
1.72
13.12
29.3
21.3
15.19
15.55
%
1.08
896
7684
648
5201
1.55
11.98
5.0
4.7
20.89
21.74
%
0.79
363
2768
300
2017
1.66
11.87
2.0
1.9
—
—
—
0
0
1022
9181
1.88
11.86
5.1
4.9
4.21
4.32
mmol/l
2.35
896
8349
144
782
1.96
11.71
1.8
1.7
—
—
—
0
0
436
3221
1.56
11.60
3.1
2.7
63.05
83.86
u/l
0.37
408
2978
946
8341
1.70
11.31
4.7
4.3
1.99
2.05
mu/l
0.68
810
7407
1039
9415
1.91
11.27
5.7
5.5
2.42
2.51
mmol/l
2.17
910
8491
461
3487
1.53
10.84
3.5
3.4
411.61
282.64
mg/l
0.26
328
2378
1009
9087
1.79
10.80
5.0
4.8
1.31
1.37
mmol/l
3.71
878
8182
541
4246
1.51
10.62
13.8
10.8
0.00
0.00
e9/l
0.39
443
3472
392
2883
1.54
10.38
2.5
2.3
3.13
3.08
mg/l
0.17
329
2446
461
3523
1.51
10.15
3.3
3.3
7.53
7.80
mmol/l
0.75
362
2911
140
791
1.87
10.08
4.4
3.7
1.15
1.89
mmol/l
1.68
110
578
475
3685
1.49
9.56
3.4
3.3
0.73
0.78
ug/l
0.78
361
2655
475
3687
1.48
9.52
4.0
4.0
10.13
9.50
mg/mmol
0.09
325
2453
976
8818
1.64
8.99
4.5
4.4
1.35
1.28
mmol/l
2.49
838
7887
373
2796
1.49
8.72
1.6
1.6
18.92
19.52
nmol/l
0.34
307
2373
989
9005
1.63
8.36
7.6
6.6
41.96
41.07
mmol/mol
2.07
887
8210
762
6577
1.45
8.27
3.9
3.4
14.97
15.05
pmol/l
0.30
644
5792
193
1263
1.63
8.23
3.8
4.3
22.91
27.03
ug/l
0.10
163
1073
480
3820
1.43
8.07
3.3
2.9
158.69
179.00
ug/l
1.03
425
3463
551
4567
1.39
7.02
2.2
2.1
91.39
91.95
pmol/l
0.10
311
2513
238
1701
1.50
6.81
3.0
2.7
2.31
2.23
g/l
1.21
214
1583
202
1405
1.53
6.56
1.8
1.8
—
—
—
0
0
661
5685
1.37
6.52
3.2
3.4
53.09
61.13
u/l
1.44
604
5202
60
298
2.07
6.30
1.5
1.5
—
—
—
0
0
227
1637
1.48
6.17
3.0
2.8
19.67
22.67
%
2.62
189
1401
55
269
2.10
6.02
1.9
2.4
124.59
129.05
g/l
0.49
41
204
27
95
2.89
5.97
1.4
1.3
—
—
—
0
0
84
480
1.81
5.86
3.4
2.8
—
—
—
0
0
197
1396
1.49
5.82
1.8
1.9
—
—
—
0
0
82
466
1.82
5.82
2.1
1.8
—
—
—
0
0
451
3707
1.35
5.70
3.4
3.2
2317.38
1851.55
ng/l
0.59
398
3272
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
486
1.78
5.63
4.1
2.7
0.31
0.34
u/ml
0.43
46
280
421
3441
1.35
5.46
4.3
3.5
2.34
2.34
mmol/l
0.26
357
2962
125
812
1.60
5.46
8.1
9.1
0.51
0.67
%
5.11
125
804
125
818
1.59
5.30
8.0
9.0
1.22
1.35
%
0.84
125
811
52
270
1.97
4.89
2.3
2.7
15.27
15.82
%
0.39
31
143
110
712
1.60
4.89
1.6
1.5
—
—
—
0
0
242
1840
1.40
4.86
3.1
2.7
11.62
12.41
umol/l
0.86
223
1722
14
29
4.87
4.81
2.1
1.9
2.16
8.43
nmol/l
0.43
14
23
510
4352
1.30
4.70
5.2
4.2
44.92
68.10
ng/l
1.11
428
3438
132
907
1.51
4.51
4.0
4.4
1.22
1.22
mmol/l
0.58
111
798
83
511
1.67
4.51
2.2
2.0
—
—
—
0
0
25
99
2.56
4.48
1.2
1.2
—
—
—
0
0
268
2108
1.35
4.33
7.7
4.1
1.02
1.02
kg/l
0.36
40
305
433
3648
1.30
4.29
2.2
2.1
77.44
77.39
nmol/l
0.01
365
3164
198
1489
1.40
4.22
6.9
7.7
5.04
5.08
kpa
0.26
192
1414
36
173
2.12
4.20
1.3
1.3
9.53
7.57
u/l
0.58
30
132
198
1490
1.40
4.20
6.8
7.7
12.16
11.77
kpa
0.53
191
1417
198
1492
1.39
4.16
6.9
7.7
0.19
1.07
mmol/l
2.67
162
1158
256
2015
1.35
4.10
1.7
1.7
1.46
1.50
mg/l
0.06
200
1589
26
110
2.39
4.09
1.4
1.3
—
—
—
0
0
200
1532
1.37
3.80
2.8
2.5
1.76
1.81
%
0.31
180
1365
277
2234
1.31
3.72
4.5
4.1
488.86
384.98
ng/l
0.18
240
1946
161
1195
1.40
3.70
4.0
3.8
1.47
2.05
mmol/l
1.27
134
988
146
1074
1.41
3.53
1.9
2.2
0.21
0.20
g/l
0.92
135
987
201
1559
1.35
3.52
6.3
6.5
1.01
1.03
mmol/l
0.27
190
1446
57
343
1.70
3.43
1.7
1.7
—
—
—
0
0
348
2921
1.27
3.40
3.1
3.1
8403.67
6779.48
umol/l
0.18
279
2499
69
440
1.60
3.33
4.5
3.5
69.93
9368.07
u/ml
0.84
61
372
156
1173
1.38
3.32
6.6
7.8
10.54
11.21
mmol/l
0.63
147
1112
391
3336
1.26
3.32
2.5
2.2
252.99
242.33
u/l
0.05
362
3111
54
324
1.70
3.29
2.2
2.3
208.03
112.09
ug/min
0.31
31
196
187
1456
1.34
3.19
3.2
4.2
222.77
252.70
u/l
3.59
178
1373
119
867
1.41
3.06
3.1
3.1
54.96
60.87
ml/min/173m2
0.91
47
363
17
68
2.52
3.05
1.2
1.2
28.35
20.25
iu/l
0.55
12
58
126
930
1.40
3.01
2.7
2.4
37.77
36.29
u/l
0.09
112
798
37
206
1.82
2.93
1.6
2.0
1.63
1.75
mmol/l
0.38
37
201
113
826
1.41
2.86
3.4
2.3
352.16
369.35
nmol/l
0.34
107
754
154
1196
1.33
2.68
2.7
2.9
8.67
10.68
umol/l
0.34
140
1072
301
2555
1.24
2.59
1.6
1.7
1.43
1.33
mmol/l
1.06
232
2089
39
230
1.72
2.58
1.2
1.3
—
—
—
0
0
245
2033
1.26
2.58
4.1
3.3
2.46
2.45
mmol/l
0.98
219
1781
150
1169
1.32
2.56
2.3
2.7
62.37
69.22
e9/l
1.64
123
918
30
166
1.83
2.46
1.9
1.9
89.38
89.11
%
0.09
30
166
223
1844
1.26
2.41
3.9
3.4
0.81
0.81
mmol/l
0.15
207
1732
287
2446
1.23
2.36
1.9
1.8
423.12
9372306.42
pmol/l
1.00
217
2006
275
2337
1.23
2.32
1.8
1.8
1114.79
1157.31
nmol/l
0.31
192
1771
353
3090
1.20
2.21
3.0
3.4
46.92
35.26
u/l
0.60
327
2935
6
14
4.30
2.15
1.3
1.1
—
—
—
0
0
58
398
1.48
2.11
2.7
3.4
4.25
4.30
pmol/l
0.17
53
341
10
37
2.72
2.07
1.4
1.3
22.75
24.38
u/l
—
10
27
12
50
2.41
2.03
1.0
1.0
—
—
—
0
0
18
90
2.02
2.01
2.6
1.9
1.11
1.81
u/field
—
9
31
15
70
2.16
1.98
1.2
1.4
—
—
—
0
0
0
54
0.00
1.85
0.0
1.0
—
—
—
0
0
13
59
2.22
1.84
1.2
1.7
—
—
—
0
0
13
59
2.22
1.84
1.2
1.7
—
—
—
0
0
15
74
2.04
1.75
1.1
1.6
—
—
—
0
0
23
134
1.73
1.67
1.7
1.6
—
—
—
0
0
22
128
1.73
1.61
4.5
2.8
—
—
—
0
0
38
255
1.51
1.59
1.3
1.3
—
—
—
0
0
38
255
1.51
1.59
1.3
1.3
—
—
—
0
0
83
644
1.31
1.53
1.6
1.9
1.68
1.51
g/l
1.00
76
553
159
1336
1.22
1.51
5.1
4.9
33.09
32.40
%
0.34
99
888
79
610
1.32
1.51
1.9
1.9
1.09
2.56
ug/l
0.87
71
543
54
393
1.39
1.51
1.2
1.4
—
—
—
0
0
6
21
2.87
1.50
1.5
1.0
—
—
—
0
0
5
16
3.13
1.44
1.4
1.1
364.56
81.14
ng/l
—
5
10
22
134
1.65
1.39
1.5
1.6
288.41
288.93
mu/l
0.00
22
125
7
29
2.42
1.39
1.1
1.4
—
—
—
0
0
13
67
1.95
1.38
1.2
1.4
2.02
1.18
promille
—
8
53
29
190
1.54
1.38
1.1
1.1
—
—
—
0
0
17
97
1.76
1.35
1.3
1.6
—
—
—
0
0
11
54
2.05
1.33
3.5
3.1
251.09
218.13
u/l
0.30
11
54
17
98
1.75
1.31
2.2
1.7
—
—
—
0
0
27
177
1.54
1.29
3.9
3.1
22.29
60.07
u/ml
0.96
27
171
11
55
2.01
1.27
1.0
1.3
—
—
—
0
0
9
44
2.05
1.27
2.2
1.4
—
—
—
0
0
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
7
30
2.34
1.12
1.4
1.3
—
—
—
0
0
22
143
1.55
1.12
1.1
1.1
1.00
31.36
iu/ml
—
6
28
102
850
1.22
1.10
1.6
1.6
—
—
—
0
0
17
104
1.64
1.09
1.4
2.4
899.33
646.12
ml
—
6
65
29
204
1.43
1.03
1.6
1.5
—
—
—
0
0
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
5
108
0.46
1.01
2.0
1.8
—
—
—
0
0
100
841
1.21
1.00
1.2
1.3
—
—
—
0
0
24
164
1.47
0.99
1.5
1.5
—
—
—
0
0
25
173
1.45
0.98
1.4
1.5
17340.13
105150.47
e6/l
1.44
15
106
10
54
1.86
0.96
5.4
3.8
75.00
85.31
nmol/l
—
10
54
30
216
1.40
0.96
3.9
4.0
1.48
1.43
%
0.03
24
194
20
133
1.51
0.94
1.5
1.5
58.92
65.43
%
0.28
12
87
170
1505
1.15
0.93
1.5
1.5
3.09
2.94
g/l
0.21
105
885
134
1166
1.17
0.92
2.8
2.5
6.46
7.33
ug/l
0.26
118
1036
21
142
1.49
0.92
3.8
4.0
—
—
—
0
0
47
368
1.29
0.89
1.1
1.1
145.67
146.16
iu/ml
—
10
125
30
220
1.37
0.88
1.1
1.3
—
—
—
0
0
17
111
1.54
0.88
1.2
1.3
12.06
13.42
u/l
0.17
17
106
8
43
1.87
0.87
1.9
2.8
—
—
—
0
0
8
43
1.87
0.87
1.9
2.8
—
—
—
0
0
11
65
1.70
0.82
1.0
1.1
0.31
1.37
u/ml
—
5
32
8
47
1.71
0.80
1.5
1.3
—
—
—
0
0
175
1572
1.13
0.79
1.2
1.2
1.83
1.35
u/ml
0.25
36
386
16
106
1.52
0.79
2.3
1.2
—
—
u/ml
—
0
0
11
66
1.67
0.79
2.0
1.6
90.82
96.45
umol/l
0.27
11
66
20
140
1.44
0.77
3.1
4.1
60.34
56.83
%
0.25
14
120
34
261
1.31
0.77
2.5
2.4
212.65
208.84
%
0.08
34
245
14
91
1.54
0.75
1.3
1.2
1.23
1.54
nmol/l
0.63
14
82
15
220
0.68
0.75
1.3
1.2
4.03
3.95
mmol/l
0.11
15
200
37
289
1.29
0.74
2.5
2.2
80.05
85.56
%
0.77
37
280
32
246
1.31
0.72
1.5
1.6
—
—
—
0
0
16
110
1.46
0.68
1.3
1.4
15.31
13.82
u/l
0.17
16
105
7
121
0.58
0.67
1.7
1.9
—
—
—
0
0
42
341
1.24
0.64
1.2
1.6
—
—
—
0
0
115
1024
1.14
0.63
2.2
2.2
10.30
12.71
nmol/l
3.03
99
889
58
489
1.20
0.62
3.6
2.7
—
—
—
0
0
58
489
1.20
0.62
3.6
2.7
3.84
3.66
g/l
0.34
48
443
58
489
1.20
0.62
3.6
2.7
7.48
7.30
g/l
0.29
48
443
21
156
1.35
0.61
3.5
2.3
2395.24
261.66
u/ml
0.51
21
151
16
221
0.72
0.60
2.0
1.3
1073.27
841.52
e6/l
0.08
11
183
16
221
0.72
0.60
1.9
1.3
16.82
44.20
e6/l
0.49
11
178
31
245
1.27
0.60
4.9
3.9
28.97
30.78
mg/l
0.10
18
159
19
254
0.74
0.59
1.3
1.2
772.79
549.95
mg/l
0.58
19
234
54
457
1.19
0.57
3.8
2.8
9.84
10.76
g/l
0.96
44
411
29
229
1.27
0.57
1.1
1.2
44.87
66.74
u/l
0.35
29
198
32
256
1.26
0.57
1.5
1.4
—
—
—
0
0
6
37
1.62
0.55
4.3
5.1
13.48
13.42
%
—
6
37
10
65
1.54
0.55
3.3
3.6
—
—
—
0
0
22
168
1.32
0.55
1.7
1.6
—
—
—
0
0
35
285
1.24
0.54
1.5
1.5
—
—
—
0
0
20
260
0.77
0.53
1.1
1.2
—
—
—
0
0
9
64
1.41
0.51
2.6
1.8
—
—
—
0
0
53
454
1.18
0.51
3.8
2.7
3.07
2.97
g/l
0.23
43
409
22
171
1.29
0.50
1.4
1.3
—
—
—
0
0
21
163
1.29
0.48
1.2
1.5
—
—
—
0
0
24
190
1.27
0.48
1.5
1.5
1425.33
1742.20
e6/l
0.23
18
137
117
1066
1.11
0.47
2.9
2.8
66.45
66.10
g/l
0.21
105
978
7
51
1.37
0.44
1.0
1.0
—
—
—
0
0
21
263
0.79
0.43
1.0
1.2
—
—
—
0
0
36
303
1.19
0.43
1.3
1.4
—
—
—
0
0
51
444
1.16
0.42
4.6
3.6
47.91
72.32
mg/l
0.89
38
362
51
444
1.16
0.42
4.6
3.6
83.44
84.97
mg/l
0.01
38
365
5
32
1.56
0.42
1.0
1.1
—
24.80
u/ml
—
0
5
34
286
1.19
0.41
1.4
1.5
251.78
263.64
ug/g
0.13
18
179
5
33
1.52
0.41
1.0
1.4
5.84
28.54
umol/l
—
5
23
22
177
1.25
0.40
1.2
1.4
—
20.36
—
0
5
19
150
1.27
0.40
1.5
1.5
7.22
6.54
mmol/l
0.61
19
141
12
88
1.37
0.40
1.0
1.0
—
—
—
0
0
8
61
1.31
0.39
1.1
1.1
—
—
—
0
0
8
61
1.31
0.39
1.1
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
11
80
1.38
0.38
4.1
3.6
54.45
26.62
u/ml
0.45
11
80
48
420
1.15
0.38
4.3
2.8
1.99
1.46
g/l
0.31
36
367
21
170
1.24
0.37
1.1
1.2
—
—
—
0
0
42
365
1.16
0.37
1.1
1.3
—
—
—
0
0
18
223
0.80
0.36
1.1
1.2
—
5.96
—
0
5
20
162
1.24
0.35
1.2
1.2
331.63
315.21
u/ml
—
8
86
9
126
0.71
0.35
1.7
1.9
—
—
—
0
0
49
433
1.14
0.35
4.7
3.6
1.07
1.92
ratio
—
6
35
10
73
1.37
0.34
1.0
1.2
—
—
—
0
0
33
283
1.17
0.34
1.7
1.7
—
—
—
0
0
54
481
1.13
0.34
3.9
3.9
1.34
1.40
mmol/l
0.18
54
472
32
274
1.17
0.34
1.6
1.5
1.39
23.63
iu/ml
—
9
57
22
184
1.20
0.30
1.3
1.5
—
—
—
0
0
28
325
0.86
0.30
1.1
1.3
—
—
—
0
0
88
813
1.09
0.30
4.5
4.2
109.62
101.69
ng/l
0.29
72
709
12
93
1.29
0.30
1.1
1.1
—
16.46
—
0
5
121
1135
1.07
0.29
3.6
3.1
289.03
238.41
ng/l
0.55
113
1039
21
176
1.20
0.29
1.1
1.1
—
—
—
0
0
34
298
1.15
0.28
1.7
1.7
—
—
—
0
0
10
129
0.77
0.28
1.9
2.3
—
—
—
0
0
18
149
1.21
0.28
1.2
1.4
105.67
135.10
u/ml
—
6
25
8
63
1.27
0.27
1.1
1.1
—
—
—
0
0
8
63
1.27
0.27
1.1
1.1
—
—
—
0
0
8
63
1.27
0.27
1.1
1.1
—
—
—
0
0
8
66
1.21
0.26
1.8
2.4
—
—
—
0
0
118
1252
0.94
0.26
1.2
1.2
5.36
14.80
u/ml
1.84
33
444
17
203
0.84
0.26
2.2
1.7
—
—
—
0
0
17
203
0.84
0.26
2.2
1.7
—
—
—
0
0
24
207
1.16
0.25
1.8
1.8
—
—
—
0
0
10
78
1.28
0.24
1.1
1.3
—
—
—
0
0
10
79
1.27
0.22
1.0
1.4
—
241.43
—
0
7
5
41
1.22
0.22
1.2
1.3
42.20
24.55
%
—
5
29
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
21.70
—
0
10
13
156
0.83
0.21
1.1
1.1
1.37
1.60
g/l
1.58
13
143
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
8
105
0.76
0.21
1.1
1.1
—
—
—
0
0
20
230
0.87
0.21
1.5
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
5.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
26
231
1.13
0.19
1.2
1.5
—
—
—
0
0
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
7
62
1.13
0.17
1.6
1.5
—
—
—
0
0
7
62
1.13
0.17
1.6
1.5
—
—
—
0
0
38
413
0.92
0.17
1.9
1.8
—
—
—
0
0
26
287
0.90
0.16
1.2
1.7
42.00
44.84
nmol/l
0.29
26
268
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
6
76
0.79
0.15
10.7
3.4
—
—
—
0
0
6
77
0.78
0.15
1.0
1.0
314.50
283.72
mg/l
—
6
68
6
77
0.78
0.15
1.0
1.1
—
63.75
—
0
8
6
80
0.75
0.15
1.0
1.2
93.33
94.91
%
—
6
75
18
160
1.13
0.14
1.7
2.5
13.20
20.08
mg/l
—
5
36
12
103
1.17
0.13
1.2
1.3
14.71
25.54
%
—
7
67
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
30
279
1.08
0.11
1.7
1.7
13510.95
20293.98
e6/l
0.61
20
204
24
260
0.92
0.11
1.6
1.6
—
—
—
0
0
5
44
1.14
0.10
1.0
1.7
620.60
1461.91
u/ml
—
5
44
16
176
0.91
0.09
1.2
1.1
—
—
—
0
0
5
61
0.82
0.08
4.0
2.4
816.80
583.07
e6/l
—
5
54
5
62
0.81
0.08
2.0
2.2
—
—
—
0
0
5
62
0.81
0.08
2.0
2.2
—
—
—
0
0
5
65
0.77
0.08
1.2
1.4
—
—
—
0
0
5
65
0.77
0.08
1.2
1.4
—
—
—
0
0
7
66
1.06
0.08
2.6
2.5
—
—
—
0
0
19
205
0.93
0.08
1.4
1.6
—
—
—
0
0
8
74
1.08
0.07
1.3
1.1
2.27
2.05
mmol/l
—
8
68
8
78
1.03
0.07
1.0
1.0
—
—
—
0
0
42
403
1.04
0.07
4.7
4.0
4.01
3.98
mmol/l
0.15
42
397
13
142
0.91
0.06
2.1
1.5
—
—
—
0
0
13
142
0.91
0.06
2.1
1.5
—
—
—
0
0
88
901
0.97
0.06
1.3
1.8
1.69
1.67
%
0.07
70
745
27
256
1.06
0.06
1.5
1.7
9.09
12.22
mg/l
0.84
21
231
11
100
1.10
0.05
1.7
1.9
3.43
4.78
mg/l
1.42
11
95
28
293
0.95
0.05
1.1
1.0
—
—
—
0
0
17
159
1.07
0.05
1.2
1.3
—
—
—
0
0
10
110
0.91
0.05
1.3
1.2
16.60
6.49
u/ml
—
5
51
10
109
0.92
0.04
1.4
1.2
2.80
3.94
u/ml
—
5
36
138
1363
1.01
0.04
8.0
8.4
—
—
—
0
0
14
132
1.06
0.02
1.4
1.6
—
—
—
0
0
39
382
1.02
0.01
3.9
2.6
36.32
37.21
g/l
0.36
29
337
41
417
0.98
0.01
1.4
1.7
37.94
38.17
u/l
0.03
33
358
13
124
1.05
0.00
1.0
1.0
—
—
—
0
0
14
134
1.05
0.00
1.4
1.6
—
—
—
0
0
14
134
1.05
0.00
1.4
1.6
—
—
—
0
0
13
134
0.97
0.00
1.4
1.6
—
—
—
0
0
13
134
0.97
0.00
1.4
1.6
—
—
—
0
0
13
128
1.02
0.00
1.4
1.5
—
—
—
0
0
130
1298
1.00
0.00
1.2
1.3
22.07
44.13
iu/ml
2.28
36
401
19
193
0.98
0.00
3.5
3.0
4.84
4.59
e9/l
0.19
19
193
21
215
0.98
0.00
1.3
1.3
1.12
0.79
nmol/l
1.11
14
174
13
135
0.96
0.00
1.4
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
9
91
0.99
0.00
1.1
1.1
8.34
7.60
mmol/l
—
9
74
0
7
0.00
0.00
0.0
1.1
—
21.19
—
0
7
8
89
0.90
0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
7.59
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
39.44
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
79
0.89
-0.00
2.4
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.1
—
—
—
0
0
5
50
1.00
-0.00
2.2
1.6
0.73
0.93
g/l
—
5
50
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
8
79
1.01
-0.00
1.5
1.5
—
—
—
0
0
5
58
0.86
-0.00
1.4
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.33
—
0
6
20
200
1.00
-0.00
3.9
3.4
56.95
59.47
%
0.29
20
200
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
-0.00
1.0
1.2
—
—
—
0
0
8
79
1.01
-0.00
1.5
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
935.67
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
62
0.97
-0.00
1.2
1.1
—
—
—
0
0
5
52
0.96
-0.00
2.6
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
22.63
—
0
8
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BLADDER – Carcinoma in situ, bladder
GWS hits: 3
This endpoint is excluded from FinRegistry analyses (omitted endpoint).